Total Value
$491.30B
Holdings Count
14
Period of Report
Sep 30, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| MERUS N V | N5749R100 | $144.44B | 1,534,141 |
| STOKE THERAPEUTICS INC | 86150R107 | $109.88B | 5,404,674 |
| GH RESEARCH PLC | G3855L106 | $104.31B | 8,601,189 |
| PROTAGONIST THERAPEUTICS INC | 74366E102 | $46.50B | 700,014 |
| CULLINAN THERAPEUTICS INC | 230031106 | $34.19B | 5,766,090 |
| C4 THERAPEUTICS INC | 12529R107 | $15.76B | 7,098,133 |
| TSCAN THERAPEUTICS INC | 89854M101 | $14.30B | 7,857,347 |
| PRECISION BIOSCIENCES INC | 74019P207 | $5.76B | 1,042,596 |
| ADC THERAPEUTICS SA | H0036K147 | $5.30B | 1,325,848 |
| PASSAGE BIO INC | 702712209 | $5.01B | 623,704 |
| DENALI THERAPEUTICS INC | 24823R105 | $3.80B | 261,687 |
| IBIO INC | 451033708 | $874.1M | 1,055,897 |
| ALLOGENE THERAPEUTICS INC | 019770106 | $677.2M | 546,119 |
| DESIGN THERAPEUTICS INC | 25056L103 | $496.6M | 65,954 |